Insider · CIK 0001457013

Nguyen Tran

Reports to the SEC for 5 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001457013

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-28	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	+57K sh	—	—	97,205
2026-07-28	PRTAPROTHENA CORP PUBLIC LTD COD Disposition to Issuer	Chief Strategy Officer and CFO	DDisposition to Issuer	−57K sh	$8.56	−$488K	40,205
2026-07-28	PRTAPROTHENA CORP PUBLIC LTD CO · Restricted Stock UnitsM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	−57K sh	—	—	0
2026-03-03	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Strategy Officer and CFO	AAward	+230K sh	—	—	230,000
2025-07-28	PRTAPROTHENA CORP PUBLIC LTD COA Award	Chief Strategy Officer and CFO	AAward	+95K sh	—	—	97,205
2025-03-05	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Strategy Officer and CFO	AAward	+108K sh	—	—	107,500
2024-02-27	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Strategy Officer and CFO	AAward	+85K sh	—	—	85,000
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42.6K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2023-08-09	Rain Oncology Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	+45K sh	$29.81	+$1.34M	48,200
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	+50K sh	$22.85	+$1.14M	98,200
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−14K sh	$72.66	−$1.02M	84,199
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−34.6K sh	$73.54	−$2.55M	49,559
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−37K sh	$74.55	−$2.76M	12,515
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−9,215 sh	$75.44	−$695K	3,300
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−100 sh	$76.04	−$7,604	3,200
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	−45K sh	—	—	0
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	−50K sh	—	—	0
2023-03-15	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	+10K sh	$6.73	+$67.3K	13,200
2023-03-15	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−4,802 sh	$48.16	−$231K	8,398
2023-03-15	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−5,198 sh	$48.68	−$253K	3,200
2023-03-15	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	−10K sh	—	—	0
2023-03-02	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Strategy Officer and CFO	AAward	+48K sh	—	—	48,000
2023-02-15	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	+10K sh	$6.73	+$67.3K	13,200
2023-02-15	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−9,336 sh	$53.30	−$498K	3,864
2023-02-15	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−664 sh	$53.87	−$35.8K	3,200
2023-02-15	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	−10K sh	—	—	10,000
2023-01-18	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	+10K sh	$6.73	+$67.3K	13,200
2023-01-18	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−7,277 sh	$55.18	−$402K	5,923
2023-01-18	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−2,085 sh	$56.32	−$117K	3,838
2023-01-18	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−638 sh	$56.97	−$36.3K	3,200
2023-01-18	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	−10K sh	—	—	20,000
2022-12-21	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	+10K sh	$6.73	+$67.3K	13,200
2022-12-21	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−3,155 sh	$58.46	−$184K	10,045
2022-12-21	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−6,845 sh	$59.21	−$405K	3,200
2022-12-21	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	−10K sh	—	—	30,000
2022-11-23	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	+10K sh	$6.73	+$67.3K	13,200
2022-11-23	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−4,547 sh	$60.53	−$275K	8,653
2022-11-23	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−3,984 sh	$61.28	−$244K	4,669
2022-11-23	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−1,469 sh	$62.28	−$91.5K	3,200
2022-11-23	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	−10K sh	—	—	40,000
2022-10-19	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	+10K sh	$6.73	+$67.3K	13,200
2022-10-19	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−2,768 sh	$55.04	−$152K	10,432
2022-10-19	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−2,520 sh	$56.30	−$142K	7,912
2022-10-19	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−4,541 sh	$57.30	−$260K	3,371
2022-10-19	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Strategy Officer and CFO	SSale	−171 sh	$58.17	−$9,947.857	3,200
2022-10-19	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Strategy Officer and CFO	MExercise/Conversion	−10K sh	—	—	50,000

Recent filings

Accepted (ET)
Jul 304
Nguyen Tran0000905148-26-003413
SEC(opens sec.gov)
Mar 54
Nguyen Tran0000905148-26-001178
SEC(opens sec.gov)
Jul 304
Nguyen Tran0000905148-25-002658
SEC(opens sec.gov)
Mar 74
Nguyen Tran0000905148-25-000886
SEC(opens sec.gov)
Feb 144
Nguyen Tran0000905148-25-000708
SEC(opens sec.gov)
Feb 294
Nguyen Tran0000905148-24-000838
SEC(opens sec.gov)
Jan 264
Nguyen Tran0001999371-24-000972
SEC(opens sec.gov)
Aug 114
Nguyen Tran0001104659-23-090701
SEC(opens sec.gov)
May 174
Nguyen Tran0001140361-23-025342
SEC(opens sec.gov)

Companies

Address

C/O PROTHENA BIOSCIENCES INC 1800 SIERRA POINT PARKWAY

BRISBANE, CA, 94005